Teva Pharmaceutical Industries reported $57M in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Aerie Pharmaceuticals AERI:US USD 49K 1000
ALKERMES ALKS:US USD 1.69M 1000
Amarin AMRN:US USD 298.6M 3.94M
Amgen AMGN:US USD 32.37B 1.03B
AstraZeneca AZN:LN USD 387M 0
Biogen BIIB:US USD 100K 0
Bristol Myers Squibb BMY:US USD 292M 0
Coherus Biosciences CHRS:US USD 7K 0
Eli Lilly And LLY:US USD 594.1M 0
Emergent Biosolutions EBS:US USD 100K 0
Endo International Ordinary Shares ENDP:US USD 63K 3K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Henry Schein HSIC:US USD 1000K 0
Horizon Pharma HZNP:US USD 23K 0
JAZZ PHA JAZZ:US USD 61K 0
Lannett LCI:US USD 43K 1000
Novartis NOVN:VX USD 878.25M 11.75M
Pacira Pharmaceuticals PCRX:US USD 46K 0
Patterson Companies PDCO:US USD 970K 1000
Perrigo Ordinary Shares PRGO:US USD 6.96B 27.4M
Phibro Animal Health PAHC:US USD 4K 0
Revance Therapeutics RVNC:US USD 82K 9K
Supernus Pharmaceuticals SUPN:US USD 54K 1000
Takeda 4502:JP JPY 1.68T 53M
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Zoetis ZTS:US USD 5M 0